Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is
responsible for the majority of cancer-related deaths worldwide. The management of …

The goal of oncology is to provide the longest possible survival outcomes with the
therapeutics that are currently available without sacrificing patients' quality of life. In lung …

Background In patients with non-small-cell lung cancer (NSCLC), the use of postoperative
radiotherapy (PORT) has been controversial since 1998, because of one meta-analysis …

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document:
Staging and multidisciplinary management of patients with early-stage non–small cell lung …

Lung cancer is the second-most commonly diagnosed cancer and the leading cause of
cancer death worldwide. The most common histological type is non-small-cell lung cancer …

Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a
narrative review - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Lung cancer is the second most common and the deadliest type of cancer worldwide.
Clinically, non‐small cell lung cancer (NSCLC) is the most common pathological type of …

Purpose During lung cancer surgery, it is very important to define tumor boundaries and
determine the surgical margin distance. In previous research, systemically application of …

Patients with locally advanced resected non–small-cell lung cancer present a high risk of
relapse. Although adjuvant platinum–based chemotherapy has become the standard of …

For patients with non–small-cell lung cancer (NSCLC), the outcomes for patients with
resectable disease are historically poor compared with other solid organ malignancies. In …